MERZ PHARMA GMBH & CO. KGAA
Patent Owner
Stats
- 55 US PATENTS IN FORCE
- 16 US APPLICATIONS PENDING
- Feb 15, 2018 most recent publication
Details
- 55 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,659 Total Citation Count
- Apr 11, 1990 Earliest Filing
- 106 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0045,733 METHODS FOR THE DETERMINATION OF THE BIOLOGICAL ACTIVITIES OF NEUROTOXIN POLYPEPTIDESNov 20, 15Feb 15, 18[G01N, C07K]
2017/0204,391 METHOD FOR THE MANUFACTURING OF DI-CHAIN PROTEINS FOR USE IN HUMANSMar 20, 17Jul 20, 17[C12N, C07K]
2017/0189,500 USE OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS FOR THE TREATMENT OF PATIENTS HAVING CERTAIN MUSCLE-RELATED DISORDERSJun 12, 15Jul 06, 17[A61K, C12N]
2017/0128,551 NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECTJun 12, 15May 11, 17[A61K]
2017/0119,863 NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECTJun 12, 15May 04, 17[A61K, C12N]
2017/0112,907 NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECTJun 12, 15Apr 27, 17[A61K]
2017/0059,558 GANGLIOSIDES FOR STANDARDIZING AND INCREASING THE SENSITIVITY OF CELLS TO BOTULINUM NEUROTOXINS IN IN VITRO TEST SYSTEMSFeb 18, 15Mar 02, 17[C12N, G01N]
2017/0035,678 COMPOSITION FOR IMPROVING THE APPEARANCE OF AGEING SKINApr 16, 15Feb 09, 17[A61K, A61Q]
2017/0027,885 1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COCHLEAR TINNITUSOct 12, 16Feb 02, 17[A61K]
2016/0184,413 FORMULATION FOR STABILIZING PROTEINS, WHICH IS FREE OF MAMMALIAN EXCIPIENTOct 23, 15Jun 30, 16[A61K, C12N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9827298 Neurotoxins exhibiting shortened biological activityNov 03, 16Nov 28, 17[A61K, C12N, A61Q, C07K]
9822223 Method of preparing a composition based on hyaluronic acidJun 14, 13Nov 21, 17[C08J, A61K, C08L, A61L]
9511114 Neurotoxins exhibiting shortened biological activityOct 19, 15Dec 06, 16[A61K, C12N, A61Q, C07K]
9498450 1-aminocyclohexane derivatives for the treatment of cochlear tinnitusSep 10, 08Nov 22, 16[A61K]
9314514 Modified neurotoxins with poly-glycine and uses thereofNov 08, 12Apr 19, 16[A61K, C12N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0289,731 MEANS AND METHODS FOR DETERMINATION OF BOTULINUM NEUROTOXIN BIOLOGICAL ACTIVITYAbandonedNov 20, 13Oct 06, 16[C12Q, C07K]
2015/0322,118 RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH ENHANCED MEMBRANE LOCALIZATIONAbandonedDec 05, 13Nov 12, 15[C07K]
2015/0232,828 METHOD FOR THE MANUFACTURING OF RECOMBINANT PROTEINS HARBOURING AN N-TERMINAL LYSINEAbandonedAug 20, 13Aug 20, 15[C12N]
2015/0073,008 Topical Application of Vinca Alkaloids for the Treatment of Actinic KeratosisAbandonedSep 11, 14Mar 12, 15[A61K]
2015/0044,709 MEANS AND METHODS FOR DETERMINING NEUROTOXIN ACTIVITY BASED ON A MODIFIED LUCIFERASEAbandonedMar 07, 13Feb 12, 15[C12Q, C12N]
2014/0377,248 METHOD FOR THE MANUFACTURING OF DI-CHAIN PROTEINS FOR USE IN HUMANSAbandonedDec 21, 12Dec 25, 14[A61K, C12N]
2014/0371,260 COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORSAbandonedMay 16, 14Dec 18, 14[A61K]
2014/0357,726 USE OF PEGYLATED ALCOHOLS FOR THE TREATMENT OF ACTINIC KERATOSISAbandonedNov 29, 12Dec 04, 14[A61K]
2014/0303,246 USE OF ADAMANTANE DERIVATIVES FOR THE TREATMENT OF ACTINIC KERATOSISAbandonedSep 07, 12Oct 09, 14[A61K]
2014/0248,332 COMPOSITION COMPRISING AN ONION EXTRACT AND LIPOSOMESAbandonedJun 21, 12Sep 04, 14[A61K]
2014/0228,440 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASESAbandonedMar 20, 14Aug 14, 14[A61K]
2014/0170,133 ALTERATION OF PROTEOLYTIC CLEAVAGE OF BOTULINUM NEUROTOXINSAbandonedJul 26, 12Jun 19, 14[A61K, C12N]
2014/0134,643 MEANS AND METHODS FOR THE DETERMINATION OF THE AMOUNT OF NEUROTOXIN POLYPEPTIDE AND OF ITS CATALYTIC AND PROTEOLYTIC ACTIVITIESAbandonedJan 16, 14May 15, 14[G01N]
2014/0107,212 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF MAST CELL MEDIATED DISEASESAbandonedDec 18, 13Apr 17, 14[A61K]
2013/0331,332 COMPOSITION COMPRISING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMAAbandonedFeb 29, 12Dec 12, 13[A61K, A61Q]
2013/0296,427 NERAMEXANE FOR THE TREATMENT OR PREVENTION OF TINNITUS RELATED WITH STRESS OR ACUTE HEARING LOSSAbandonedJan 19, 12Nov 07, 13[A61K]
2013/0165,522 GEL FORMULATIONS FOR THE TOPICAL USE OF 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVESAbandonedJun 17, 11Jun 27, 13[A61K]
2013/0158,235 SELECTIVE MANUFACTURE OF RECOMBINANT NEUROTOXIN POLYPEPTIDESAbandonedAug 10, 11Jun 20, 13[C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
